Search results for "slas europe 2018"
Selected Filters:
SCIEX Supports Cancer Survival Research Through Donation to World Cancer Research Fund
By partnering with WCRF, SCIEX supports research that benefits cancer patients
8 top technology news stories from SLAS2022
The latest news and technological innovations from SLAS2022 International Conference and Exhibition
Revolutionizing quat pesticide determination and quantitation workflows to protect food supply
The Thermo Scientific Dionex IonPac CS21 ion exchange column enables reliable, accurate, and compliant food safety analysis
RedShift BioAnalytics announces launch of next generation Apollo for ultra-sensitive biophysical characterization of biomolecules
Apollo incorporates major advances over first-generation instrument to support rapidly growing market demand
ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement
License agreement to enhance GenScript’s CRISPR offering for gene and cell therapy research
Getting ready for In Vitro Diagnostic Regulation (IVDR)
Catch up on this on-demand webinar and register for part 2 to learn everything you need to know to get ready for IVDR
Glucagon ELISA
Ansh LabsThe Glucagon Enzyme Linked Immunosorbent Assay (ELISA) kit provides materials for the quantitative measurement of Glucagon in human plasma and other biological fluids.
Dr. Anne Wyllie takes saliva-based testing beyond Covid-19
The significant contributions of Dr. Anne Wyllie to Covid-19 testing and clinical research at the Yale School of Public Health
How micro-circuits in the brain regulate fear
Researchers have discovered that the activation of identified central amygdala neurons can suppress fear responses
New data for Roche’s OCREVUS reinforce significant benefit on slowing disease progression in relapsing and primary progressive multiple sclerosis
OCREVUS significantly slowed loss of brain tissue within T2 MRI lesions in primary progressive multiple sclerosis (PPMS) in post-hoc analysis of Phase III ORATORIO study
Vote for Best New General Lab and Analytical Science Products in the Scientists’ Choice Awards
For the chance to win a $500/£400/450€ Amazon.com Gift Card, cast your vote for the new product which has made the most impact in your lab
Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal
Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated
How CLSI makes antimicrobial susceptibility testing possible
Dr. Barbara Jones, CEO of CLSI, discusses emerging resistance trends, the importance of updated breakpoints, and how CLSI continues to support laboratories navigating the evolving AMR landscape























